News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Hagop Kantarjian: Updated results of our frontline trial of FLAG-IDA+VEN
Hagop Kantarjian/mdanderson.org
Feb 26, 2025, 10:02

Hagop Kantarjian: Updated results of our frontline trial of FLAG-IDA+VEN

Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, shared a post on X about a paper he co-authored with colleagues published in Leukemia:

“Updated results of our frontline trial of FLAG-IDA+VEN, showing CRc in 95% of newly diagnosed AML. Responses were seen across all ELN22 risk groups, with 90% MRD neg. In RR AML, 79% first salvage and TP53wt attained CRc.”

“Long-term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia”

Authors: Courtney DiNardo, Wei-Ying Jen, Koichi Takahashi, Marina Konopleva, Hagop Kantarjian et al.

Hagop Kantarjian: Updated results of our frontline trial of FLAG-IDA+VEN

More posts featuring Hagop Kantarjian.

Acute Myeloid Leukemia AML cancer Courtney DiNardo Hagop Kantarjian Koichi Takahashi Marina Konopleva OncoDaily Oncology venetoclax Wei Ying Jen
Special Coverage
Insight
Feb 26, 2025, 10:02
Hagop Kantarjian: Updated results of our frontline trial of FLAG-IDA+VEN
Blog
Feb 26, 2025, 10:01
Ravi Mehrotra: The impact of a cancer diagnosis goes far beyond the patient
Blog
Feb 26, 2025, 09:56
Cancer care is not a luxury - City Cancer Challenge
Blog
Feb 26, 2025, 09:55
Wafaa M Rashed: Pediatric Cancer Research Fund - A Battle We Cannot Afford to Lose
Blog
Feb 26, 2025, 09:50
Nirmala Bhoo Pathy: Cancer care is more than just medicine, it’s about people
Blog
Feb 26, 2025, 09:48
The Ministry of Health of Georgia and C/Can signed a four-year Collaboration Agreement - City Cancer Challenge
Blog
Feb 26, 2025, 09:46
Cuts to Medicaid need to be off the table - ACS CAN
Science
Feb 26, 2025, 09:43
Trudy Wu: Incredible GI leaders paving the path for EBRT in HCC
Blog
Feb 26, 2025, 09:41
Penilla Gunther: How Cancer and CVDs are connected to many other disease areas
Blog
Feb 26, 2025, 09:40
Ruben Mesa: Celebrating the amazing leadership team of the Wake Forest University School of Medicine
Blog
Feb 26, 2025, 09:34
Arturo LoAIza-Bonilla: Proud of the work of our ASCO Government Relations Committee
Blog
Feb 26, 2025, 09:26
New translational insights on immune activation in refractory gastric cancer presented at AACRIO25 - Agenus